ASX Announcements

Filter by
  • All
  • Announcements
  • Financial Reports
  • Presentations
  • Press Releases
  • Research Reports
  • Company Updates
Document Name Date Added
Appendix 3B Additional Information REM Systems Limited
12/06/2018
Appendix 3B Share Issue REM Systems Limited
12/06/2018
Share Issue Cleansing Notice REM Systems Limited
12/06/2018
Significant Acquisition in New Zealand (REM Systems)
08/06/2018
Appendices 3X (2) & 3Z (2) – 04JUN
04/06/2018
Changes to Board and Management
30/05/2018
Trading & Acquisitions Update (Apr 2018)
24/04/2018
Notice of ceasing to be a substantial holder (Apr 2018)
24/04/2018
Appendix 3B – DRP Shares (Apr 2018)
23/04/2018
Update Dividend Distribution (Mar 2018)
19/03/2018
Dividend Reinvestment Plan Issue Price (Mar 2018)
19/03/2018
Appendix 3B Amendment Retail Entitlement Offer
14/03/2018
Notice of Change of Interests of Substantial Holder – Karst Peak Capital
06/03/2018
Notice of Initial Substantial Holder – Karst Peak Asia
06/03/2018
Appendix 3B – Retail Entitlement Offer
06/03/2018
Change of 2 Director’s Interest Notices (Sam,Newton)
02/03/2018
Appendix 3B (Anaequip, Surgical Specialties)
02/03/2018
Completion of Retail Entitlement Offer
01/03/2018
Acquisition of Surgical Specialties Group
28/02/2018
Change of Director’s Interest Notice – Tanner
23/02/2018
Becoming a Substantial Holder – Karst Peak
20/02/2018
Appendix 3B Update & Placement Cleansing Notice
19/02/2018
Despatch of Retail Entitlement Offer Booklet
15/02/2018
Letter to Ineligible Retail Shareholders
15/02/2018
Change of Director’s Interest Notice – 2 Directors
14/02/2018
Retail Offer Booklet
12/02/2018
Completion of Institutional Offer
12/02/2018
Capital Raising & Acquisitions
08/02/2018
Half Yearly Report & Accounts
08/02/2018
Update – Dividend Distribution PGC
08/02/2018
Notice of Dividend/Distribution PGC
08/02/2018
Half Yearly Accounts (31 December 2017) Amendment to Note
08/02/2018
Appendix 3B – Cleansing Notice, Capital Raising (Feb 2018)
08/02/2018
ASX Trading Halt (Feb 2018)
07/02/2018
Acquisition of South Australian Medical Distributor Business – Anaequip
25/01/2018
Appendix 3B – Cleansing Notice Anaequip (Jan 2018)
25/01/2018
Chief Executive Officer Transition & Director Resignation
22/01/2018
Cease Substantial Holding – Pie Funds Management
16/01/2018
Change in Substantial Holding – Pie Funds Management
10/01/2018
Update on Acquisitions, Investments and Outlook
27/12/2017
Collaboration Agreement with Toshiba Medical for MIDAS Software
15/12/2017
Acquisition of Immunohaematology Business
01/12/2017
Results of Meeting (AGM 2017)
22/11/2017
AGM Presentation to Shareholders, November 2017
22/11/2017
Notice of General Meeting & Shareholder Proxy Form
20/10/2017
Change in Substantial Holding – Pie Funds Management (Oct 2017)
10/10/2017
Change of Directors’ Interest Notices (2) – Sam, Simari
09/10/2017
Appendix 3B – DRP Shares (Oct 2017)
03/10/2017
CEO Transition Announcement
27/09/2017
Bell Potter Report – FY18 Another Year of Growth for Paragon Care
15/09/2017
Dividend Reinvestment Plan Issue Price (11/09/2017)
11/09/2017
Appendix 3B – Medtek & Western Biomedical
14/08/2017
Acquisition of Medtek Pty Ltd
14/08/2017
Petra Capital Report – Paragon Care Limited, Well Equipped
10/08/2017
Paragon Care 2017 Annual Report
08/08/2017
Corporate Governance Statement & Appendix 4G
07/08/2017
Notification of Dividend Distribution
07/08/2017
Full Year Results Investor Presentation FY17
07/08/2017
Appendix 4E & Final Report 2017
07/08/2017
Full Year Results Announcement FY17
07/08/2017
Equity Report by Shaw and Partners – 4 July 2017
05/07/2017
Company Secretary Resignation – Stephen Munday
30/06/2017
CFO Resignation – Stephen Munday
26/05/2017
Paragon Care Initiation Report Q4-FY17
09/05/2017
Change of Three Directors Interest Notice
07/04/2017
Appendix 3B – DRP – 4 April 2017
05/04/2017
DRP Issue Price – 13 March 2017
14/03/2017
Update to Notification of Dividend Distribution – March 2017
13/03/2017
Change in Substantial Holding (First Samuel Limited)
10/02/2017
Half Year Results Presentation – February 2017
09/02/2017
Appendix 4D & Half Year Accounts – February 2017
09/02/2017
Notification of Dividend Distribution – February 2017
09/02/2017
Supply Agreement with Total Face Group
08/12/2016
Change of Director’s Interest Notice (4)
23/11/2016
Results of Meeting
22/11/2016
Chairmans Address & Presentation to Shareholders
22/11/2016
Notice of Annual General Meeting & Proxy Form
17/10/2016
EMG Acquisition Settled, Appendix 3B, Cleansing Notice
10/10/2016
Dividend Reinvestment Plan Issue Price
19/09/2016
Acquisition of Electro Medical Group
13/09/2016
Argonaut Equity Research Report – PGC Strong Pulse
11/08/2016
Bell Potter Research Report – PGC Set for High Quality Earnings Growth
11/08/2016
Annual Report FY16
08/08/2016
Corporate Governance Statement & Appendix 4G
08/08/2016
PGC Dividend Distribution
08/08/2016
FY 2016 Results Release Announcement
08/08/2016
FY 2016 Results – Investor Presentation
08/08/2016
Appendix 4E – Preliminary Final Report FY16
08/08/2016
New Issue, Appendix 3B & Cleansing Notice
18/07/2016
Acquisition of Midas Software Solutions
08/07/2016
FY16 Earnings Update
30/06/2016
Initial Director’s Interest Notice – Geoffrey Sam
06/06/2016
Non-Executive Director Appointment – Geoffrey Sam
06/06/2016
Paragon Care Company Update
02/05/2016
Change of Director’s Interest Notice – Mr Tanner & Mr Newton
13/04/2016
Appendix 3B – DRP Shares
06/04/2016
Change of Director’s Interest Notice – Mr Simari
06/04/2016
Index Announcement
11/03/2016
Dividend Reinvestment Plan Issue Price
10/03/2016
Appendix 3A – Dividend Distribution
08/02/2016
Half Yearly Report 1H-FY16 – Press Release
08/02/2016
Half Yearly Report 1H-FY16 – Presentation
08/02/2016
Appendix 4D – Half Year Report 1H-FY16 – Accounts
08/02/2016
Code of Conduct
18/12/2015
Audit & Risk Management Committee Charter
18/12/2015
Board Charter
18/12/2015
Annual Report FY15
18/12/2015
Appendix 3X – Initial Director’s Interest Notice
17/12/2015
Righst Issue Close & Shortfall Notification
17/12/2015
Western Biomedical Acquisition Completed
14/12/2015
Notice of Annual General Meeting & Proxy Form
14/12/2015
Meditron Acquisition Completed, Cleansing Notice, Appendix 3B
14/12/2015
Change of Head Office and Registered Office
10/12/2015
Appendix 3Y – Change of Director’s Interest Notice
09/12/2015
Argonaut Equity Research Report – PGC Healthy Growth Initiation
01/12/2015
AGM Results of Meeting
30/11/2015
AGM Chairman’s Address & Managing Director’s Presentation
30/11/2015
Designs for Vision Aquisition Completed, Cleansing Notice, Appendix 3B
09/10/2015
Appendix 3Y – Change of Director’s Interest Notice x 4
09/10/2015
Corporate Governance Statement – October 2015
07/10/2015
Appendix 3B – Placement Cleansing Notice
06/10/2015
General Meeting – Results of Meeting
28/09/2015
General Meeting – No trading halt to be called
28/09/2015
Appendix 3Y – Change of Director’s Interest Notice – Simari, Newton
18/09/2015
Appendix 3B – DRP
17/09/2015
Bell Potter Report on PGC
10/09/2015
Non-Renounceable Rights Issue Info Booklet
03/09/2015
DRP Issue Price
31/08/2015
Rights Issue Information Booklet
26/08/2015
Rights Issue Cleansing Notice & Appendix 3B
26/08/2015
Notice of Meeting
26/08/2015
Letter to Shareholders
26/08/2015
Amended Timetable re Rights Issue & EGM
25/08/2015
Appendix 4E – Preliminary Final Report
18/08/2015
Appendix 3A – Notification of Dividend
18/08/2015
Appendix 4G – Corporate Governance Disclosures
18/08/2015
Financial Highlights FY15 Full Year
18/08/2015
Acquisitions, Placement & Rights Issue
18/08/2015
Appointment of Alternate Director
12/06/2015
Appendix 3Y – Change of Director’s Interest Notice
31/03/2015
DRP Price & Appendix 3B
27/03/2015
Company Secretary Appointment / Resignation
13/03/2015
Half Yearly Report 1H-FY14 – Investor Presentation
26/02/2015
Dividend Reinvestment Plan (DRP) Rules – Information Booklet
31/01/2015
Bell Potter Report on PGC
21/01/2015
Annual Report FY14
18/12/2014
Continuous Disclosure Policy
18/07/2014
Nomination & Remuneration Committee Charter
18/07/2014
Annual Report FY13
18/12/2013
Annual Report FY12
18/12/2012
Annual Report FY11
18/12/2011
Annual Report FY10
18/12/2010
Annual Report FY09
18/12/2009